Virtus Biotech ETF
15 hedge funds and large institutions have $12.2M invested in Virtus Biotech ETF in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 15 → 15 (0)
0.49% less ownership
Funds ownership: 42.96% → 42.47% (-0.49%)
3% less capital invested
Capital invested by funds: $12.6M → $12.2M (-$346K)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$180K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$7.53K |
| 3 |
Morgan Stanley
New York
|
+$1.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMG
Smart Money Group
Eastland,
Texas
|
-$165K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$68.2K |
| 3 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$55.8K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$22.9K |
| 5 |
RWB
RMR Wealth Builders
Montclair,
New Jersey
|
-$11.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5.97M | +$180K | +3,228 | +3% |
|
|
SMG
2
Smart Money Group
Eastland,
Texas
| $3.33M | -$165K | -2,958 | -4% |
|
3
Citadel Advisors
Miami,
Florida
| $1.11M | -$4.57K | -82 | -0.4% |
|
|
FAIM
4
Financial Advocates Investment Management
Olympia,
Washington
| $544K | -$55.8K | -1,000 | -9% |
|
|
5
Stifel Financial
St. Louis,
Missouri
| $431K | +$7.53K | +135 | +2% |
|
6
LPL Financial
San Diego,
California
| $376K | -$7.75K | -139 | -2% |
|
|
7
Morgan Stanley
New York
| $108K | +$1.23K | +22 | +1% |
|
|
NFG
8
Next Financial Group
Houston,
Texas
| $102K | -$2.51K | -45 | -2% |
|
|
RWB
9
RMR Wealth Builders
Montclair,
New Jersey
| $76K | -$11.9K | -214 | -13% |
|
|
10
Osaic Holdings
Scottsdale,
Arizona
| $63K | -$22.9K | -410 | -25% |
|
|
11
UBS Group
Zurich,
Switzerland
| $61K | -$68.2K | -1,222 | -51% |
|
|
FWM
12
Focused Wealth Management
Newburgh,
New York
| $37K | – | – | – |
|
|
SWA
13
SOA Wealth Advisors
New York
| $7K | – | – | – |
|
|
CFB
14
Cullen/Frost Bankers
San Antonio,
Texas
| $4K | – | – | – |
|
15
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
BBP Hedge Fund Activity: Q1 2021 in Review
15 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2021, worth a combined $12.2M — down 2.8% from $12.6M a quarter earlier.
Fund positioning in BBP was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 8 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $180K. The largest seller was Smart Money Group, cutting an estimated $165K.
- 15 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $12.2M of Virtus Biotech ETF stock for Q1 2021, down 2.8% quarter-over-quarter.
- 0 funds opened new Virtus Biotech ETF positions in Q1 2021 and 0 closed out.
- The largest Virtus Biotech ETF buyer in Q1 2021 was Royal Bank of Canada, an estimated $180K added.
- The largest Virtus Biotech ETF seller in Q1 2021 was Smart Money Group, an estimated $165K sold.
Based on aggregated 13F filings for Q1 2021.